PALISADE BIO, INC. - PALI
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Commodore Capital LP | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Commodore Capital Master LP | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Robert Egen Atkinson | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Michael Kramarz | 0.0% | 0 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Soleus Capital Master Fund, L.P. | 7.5% | 13,063,687 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Soleus Capital, LLC | 7.5% | 13,063,687 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Soleus Capital Group, LLC | 7.5% | 13,063,687 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Soleus Capital Management, L.P. | 7.5% | 13,063,687 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Soleus GP, LLC | 7.5% | 13,063,687 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Guy Levy | 7.5% | 13,063,687 | View |
| May 27, 2026 | SCHEDULE 13G | Soleus Capital Master Fund, L.P. | 5.4% | 9,353,687 | View |
| May 27, 2026 | SCHEDULE 13G | Soleus Capital, LLC | 5.4% | 9,353,687 | View |
| May 27, 2026 | SCHEDULE 13G | Soleus Capital Group, LLC | 5.4% | 9,353,687 | View |
| May 27, 2026 | SCHEDULE 13G | Soleus Capital Management, L.P. | 5.4% | 9,353,687 | View |
| May 27, 2026 | SCHEDULE 13G | Soleus GP, LLC | 5.4% | 9,353,687 | View |
| May 27, 2026 | SCHEDULE 13G | Guy Levy | 5.4% | 9,353,687 | View |
| May 15, 2026 | SCHEDULE 13G/A | Commodore Capital LP | 7.2% | 12,366,776 | View |
| May 15, 2026 | SCHEDULE 13G/A | Commodore Capital Master LP | 7.2% | 12,366,776 | View |
| May 15, 2026 | SCHEDULE 13G/A | Robert Egen Atkinson | 7.2% | 12,366,776 | View |
| May 15, 2026 | SCHEDULE 13G/A | Michael Kramarz | 7.2% | 12,366,776 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 0.2% | 411,772 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 0.2% | 411,772 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 0.2% | 411,772 | View |
| May 15, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 9.9% | 17,620,479 | View |
| May 15, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 9.9% | 17,620,479 | View |
| May 15, 2026 | SCHEDULE 13G/A | Rajeev Shah | 9.9% | 17,620,479 | View |
| May 15, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 9.9% | 17,620,479 | View |
| May 15, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 7.9% | 14,113,863 | View |
| May 15, 2026 | SCHEDULE 13G/A | Joseph Edelman | 7.9% | 14,113,863 | View |
| May 15, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 7.9% | 14,113,863 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.